Ohtani K - Search Results

1

Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients.

Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M, Shimomura Y. Shimizu H, et al. Among authors: ohtani k. Diabetes Res Clin Pract. 1995 Apr;28(1):35-40. doi: 10.1016/0168-8227(95)01056-j. Diabetes Res Clin Pract. 1995. PMID: 7587910 Clinical Trial.

2

Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese Type 2 diabetic (T2DM) patients.

Shimizu H, Ohtani KI, Tsuchiya T, Sato N, Tanaka Y, Takahashi H, Uehara Y, Inukai T, Mori M. Shimizu H, et al. Among authors: ohtani ki. Diabetes Nutr Metab. 2000 Apr;13(2):75-9. Diabetes Nutr Metab. 2000. PMID: 10898124

3

Effect of eicosapentaenoic acid ethyl on urine albumin excretion in NIDDM.

Shimizu H, Sato N, Tanaka Y, Kashima K, Ohtani K, Mori M. Shimizu H, et al. Among authors: ohtani k. Diabetes Care. 1993 Oct;16(10):1406-8. doi: 10.2337/diacare.16.10.1406. Diabetes Care. 1993. PMID: 8269805 No abstract available.

4

Increased plasma thrombin-antithrombin III complex levels in non-insulin dependent diabetic patients with albuminuria are reduced by ethyl icosapentatenoate.

Shimizu H, Ohtani K, Tanaka Y, Fukatsu A, Uehara Y, Sato N, Mori M. Shimizu H, et al. Among authors: ohtani k. Thromb Haemost. 1995 Nov;74(5):1231-4. Thromb Haemost. 1995. PMID: 8607100 Clinical Trial.

5

Acarbose partially prevents the development of diabetes mellitus by multiple low-dose streptozotocin administration.

Negishi M, Shimizu H, Ohtani K, Mori M. Negishi M, et al. Among authors: ohtani k. Diabetes Res Clin Pract. 1996 Jun;33(1):15-9. doi: 10.1016/0168-8227(96)01254-5. Diabetes Res Clin Pract. 1996. PMID: 8877271

6

Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients.

Sato N, Kashima K, Uehara Y, Ohtani K, Shimizu H, Mori M. Sato N, et al. Among authors: ohtani k. Diabetes Care. 1997 Jun;20(6):995-8. doi: 10.2337/diacare.20.6.995. Diabetes Care. 1997. PMID: 9167113 Clinical Trial.

7

Attainment of glycaemic goals by step-up therapy with biphasic insulin aspart-70/30 in Japanese type 2 diabetic patients.

Hosoi Y, Ohtani K, Shimizu H, Kashima K, Sato N, Akiyama H, Mori M. Hosoi Y, et al. Among authors: ohtani k. Endocr J. 2011;58(2):131-5. doi: 10.1507/endocrj.k10e-307. Epub 2010 Dec 21. Endocr J. 2011. PMID: 21186332 Free article.

8

Incidence of β3-adrenergic receptor polymorphism and prediction of successful weight reduction with mazindol therapy in severely obese Japanese subjects.

Shimizu H, Tsuchiya T, Oh-I S, Ohtani K, Okada S, Mori M. Shimizu H, et al. Among authors: ohtani k. Obes Res Clin Pract. 2007 May;1(2):I-II. doi: 10.1016/j.orcp.2007.02.002. Obes Res Clin Pract. 2007. PMID: 24351452

9

Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells.

Ohtani KI, Shimizu H, Sato N, Mori M. Ohtani KI, et al. Endocrinology. 1998 Jan;139(1):172-8. doi: 10.1210/endo.139.1.5670. Endocrinology. 1998. PMID: 9421412

10

Orchiectomy and response to testosterone in the development of obesity in young Otsuka-Long-Evans-Tokushima Fatty (OLETF) rats.

Shimizu H, Ohtani KI, Uehara Y, Abe Y, Takahashi H, Tsuchiya T, Sato N, Ibuki Y, Mori M. Shimizu H, et al. Among authors: ohtani ki. Int J Obes Relat Metab Disord. 1998 Apr;22(4):318-24. doi: 10.1038/sj.ijo.0800586. Int J Obes Relat Metab Disord. 1998. PMID: 9578236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters